<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02180945</url>
  </required_header>
  <id_info>
    <org_study_id>NV-ONY-001</org_study_id>
    <nct_id>NCT02180945</nct_id>
  </id_info>
  <brief_title>ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae</brief_title>
  <acronym>dAVF</acronym>
  <official_title>ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae. A French, Observational, Prospective, Multicentric, Single Arm and Open Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Neurovascular Clinical Affairs</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Neurovascular Clinical Affairs</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the safety and performance post last embolization
      with Onyx
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2013</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Neurological clinical evolution</measure>
    <time_frame>1Month post procedure</time_frame>
    <description>Improved, Stable, Worsened, death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Healing rate</measure>
    <time_frame>3-6 months post procedure</time_frame>
    <description>Number of patients with No residual early venous return</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>3-6 months after procedure</time_frame>
    <description>The number of adverse events (causing death or otherwise)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>pre-procedure and at 3-6 months</time_frame>
    <description>Describe EuroQoL quality of life survey results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe functional independence</measure>
    <time_frame>1 and 12 months after procedure</time_frame>
    <description>Describe mRS scores assessed by a certified physician</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical performance of the product</measure>
    <time_frame>12 months after procedure</time_frame>
    <description>Volume injected per embolization session</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">110</enrollment>
  <condition>Arteriovenous Fistula</condition>
  <arm_group>
    <arm_group_label>Intracranial Dural Arteriovenous Fistula</arm_group_label>
    <description>Adult patients requiring endovascular treatment of Intracranial Dural Arteriovenous Fistulae.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients presenting at the participating centers for whom an intracranial dAVF (not
        previosly treated) needs to be treated (unrelated to the planned treatment) and who agree
        to the collection and transmission of related data.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has an intracranial dAVF which could be treated by ONYX embolization,
             whether or not associated to other embolization products.

          -  The patient is at least 18 years of age.

        Exclusion Criteria:

          -  The patient needs to be treated for the dAVF with another treatment option (for
             example by surgery) than embolization within a period of less than 6 months (to be
             counted as from the first treatment)

          -  The patient participates to another clinical study during the treatment period for
             his/her dAVF, evaluating another medical devices, procedure or medication.

          -  The patient refuses to give consent to the collection and processing of data required
             for centralized monitoring.

          -  A condition which could jeopardize follow-up of the patient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Cognard, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frédéric Ricolfi, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire Dijon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Courthéoux, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurent Spelle, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Beaujon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Covidien</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2014</study_first_submitted>
  <study_first_submitted_qc>July 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2014</study_first_posted>
  <last_update_submitted>March 7, 2018</last_update_submitted>
  <last_update_submitted_qc>March 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dAVF</keyword>
  <keyword>Arteriovenous fistula</keyword>
  <keyword>ONYX</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Central Nervous System Vascular Malformations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

